Search PDMR transactions

Notifier
Name of person with notification obligation
Anthon Jahreskog
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Anthon Jahreskog
Position
Member of the Board of Directors
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
INFANT BACTERIAL THERAPEUTICS AB
Issuer´s LEI code
2138008KVBXCRJGP6Z26
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Infant Bacterial Therapeutics AB ser. B SE0008015259 Acquisition 37 Quantity 96.20 SEK 17/05/2024 NASDAQ STOCKHOLM AB
Share Infant Bacterial Therapeutics AB ser. B SE0008015259 Acquisition 88 Quantity 96.80 SEK 17/05/2024 NASDAQ STOCKHOLM AB
Share Infant Bacterial Therapeutics AB ser. B SE0008015259 Acquisition 56 Quantity 97.20 SEK 17/05/2024 NASDAQ STOCKHOLM AB
Share Infant Bacterial Therapeutics AB ser. B SE0008015259 Acquisition 89 Quantity 97.60 SEK 17/05/2024 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Infant Bacterial Therapeutics AB ser. B SE0008015259 Acquisition 17/05/2024 NASDAQ STOCKHOLM AB 270 (Quantity) 97.06444444 SEK
Total: 270
<< Back